Abstract
Introduction
The European CRT Survey II was introduced to offer insights into CRT implantation practice in Europe. We compared the national data from the participating German centres with that of the other European countries with regard to differences in patient selection, implant results, and initial properties.
Methods and results
11,088 patients were enrolled in 288 centres from 42 countries between 2015 and 2017. Of these, 675 (6.1%) were included in 17 centres in Germany. Patients from Germany were older, had more comorbidities and more symptoms of heart failure (HF) than patients from other European countries. There were no differences with regard to HF aetiology and guideline-directed medical treatment was overall well implemented. There was a high use of CRT in patients with atrial fibrillation, even higher in German patients. CRT was most often applied due to HF with wide QRS complex (class I recommendation) but with relatively higher frequency in Germany due to HF with primary indication for an implantable cardioverter-defibrillator (class IIb) or a pacemaker with expected pacing dependency (class I). The overall implant success rate was high with some differences in the implant procedure. The use of remote monitoring was lower in Germany.
Conclusion
This analysis from the European CRT Survey II overall shows good guideline adherence, high implantation success and a low rate of complications in daily practice. There are some regional differences in baseline characteristics, CRT indication, and procedural aspects. The use of remote monitoring in Germany lags behind other European countries.
Graphic abstract
Similar content being viewed by others
References
Cazeau S, Leclercq C, Lavergne T et al (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–880. https://doi.org/10.1056/NEJM200103223441202
Cazeau S, Ritter P, Bakdach S et al (1994) Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 17:1974–1979
Abraham WT, Fisher WG, Smith AL et al (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853. https://doi.org/10.1056/NEJMoa013168
Cleland JGF, Daubert J-C, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549. https://doi.org/10.1056/NEJMoa050496
Cleland JG, Abraham WT, Linde C et al (2013) An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J 34:3547–3556. https://doi.org/10.1093/eurheartj/eht290
Goldenberg I, Kutyifa V, Klein HU et al (2014) Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med 370:1694–1701. https://doi.org/10.1056/NEJMoa1401426
Linde C, Abraham WT, Gold MR et al (2008) Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 52:1834–1843. https://doi.org/10.1016/j.jacc.2008.08.027
Moss AJ, Hall WJ, Cannom DS et al (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338. https://doi.org/10.1056/NEJMoa0906431
Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975. https://doi.org/10.1002/ejhf.592
Dickstein K, Bogale N, Priori S et al (2009) The European cardiac resynchronization therapy survey. Eur Heart J 30:2450–2460. https://doi.org/10.1093/eurheartj/ehp359
Dickstein K, Normand C, Anker SD et al (2015) European Cardiac Resynchronization Therapy Survey II: rationale and design. Europace 17:137–141. https://doi.org/10.1093/europace/euu312
Dickstein K, Normand C, Auricchio A et al (2018) CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11,088 patients-who is doing what to whom and how? Eur J Heart Fail 20:1039–1051. https://doi.org/10.1002/ejhf.1142
Abraham WT, Young JB, León AR et al (2004) Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 110:2864–2868. https://doi.org/10.1161/01.CIR.0000146336.92331.D1
Cleland JGF, Freemantle N, Erdmann E et al (2012) Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. Eur J Heart Fail 14:628–634. https://doi.org/10.1093/eurjhf/hfs055
Young JB, Abraham WT, Smith AL et al (2003) Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 289:2685–2694. https://doi.org/10.1001/jama.289.20.2685
Delnoy PPHM, Ottervanger JP, Luttikhuis HO et al (2007) Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol 99:1252–1257. https://doi.org/10.1016/j.amjcard.2006.12.040
Gasparini M, Auricchio A, Regoli F et al (2006) Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 48:734–743. https://doi.org/10.1016/j.jacc.2006.03.056
Leclercq C, Walker S, Linde C et al (2002) Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 23:1780–1787. https://doi.org/10.1053/euhj.2002.3232
Wilton SB, Leung AA, Ghali WA et al (2011) Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 8:1088–1094. https://doi.org/10.1016/j.hrthm.2011.02.014
Tang ASL, Wells GA, Talajic M et al (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363:2385–2395. https://doi.org/10.1056/NEJMoa1009540
Brignole M, Botto GL, Mont L et al (2012) Predictors of clinical efficacy of “Ablate and Pace” therapy in patients with permanent atrial fibrillation. Heart 98:297–302. https://doi.org/10.1136/heartjnl-2011-301069
Ganesan AN, Brooks AG, Roberts-Thomson KC et al (2012) Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol 59:719–726. https://doi.org/10.1016/j.jacc.2011.10.891
Gasparini M, Auricchio A, Metra M et al (2008) Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 29:1644–1652. https://doi.org/10.1093/eurheartj/ehn133
Hayes DL, Boehmer JP, Day JD et al (2011) Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 8:1469–1475. https://doi.org/10.1016/j.hrthm.2011.04.015
Benz AP, Vamos M, Erath JW et al (2018) ICD lead type and RV lead position in CRT-D recipients. Clin Res Cardiol 107:1122–1130. https://doi.org/10.1007/s00392-018-1286-3
Schiedat F, Schöne D, Aweimer A et al (2019) Multipoint left ventricular pacing with large anatomical separation improves reverse remodeling and response to cardiac resynchronization therapy in responders and non-responders to conventional biventricular pacing. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01499-7
Raatikainen MJP, Arnar DO, Merkely B et al (2017) A Decade of information on the use of cardaic implantable electronic devices and interventional electrophysiological procedures in the European Society of cardiology countries: 2017 report from the European heart rhythm association. Europace 19:ii1–ii90. https://doi.org/10.1093/europace/eux25
Curtis AB, Worley SJ, Adamson PB et al (2013) Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med 368:1585–1593. https://doi.org/10.1056/NEJMoa1210356
Ruschitzka F, Abraham WT, Singh JP et al (2013) Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med 369:1395–1405. https://doi.org/10.1056/NEJMoa1306687
Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 15:1070–1118. https://doi.org/10.1093/europace/eut206
Herold R, Hoffmann W, van den Berg N (2018) Telemedical monitoring of patients with chronic heart failure has a positive effect on total health costs. BMC Health Serv Res. https://doi.org/10.1186/s12913-018-3070-5
Hindricks G, Taborsky M, Glikson M et al (2014) Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet 384:583–590. https://doi.org/10.1016/S0140-6736(14)61176-4
Geller JC, Lewalter T, Bruun NE et al (2019) Implant-based multi-parameter telemonitoring of patients with heart failure and a defibrillator with vs. without cardiac resynchronization therapy option: a subanalysis of the IN-TIME trial. Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01447-5
Acknowledgements
A special thanks to the other members and initiators of the European CRT Survey II, the European Society of Cardiology, the Heart Failure Association and the European Heart Rhythm Association. Thanks to our sponsors Medtronic (Minneapolis, MN, USA), Boston Scientific (Marlborough, MA, USA), St. Jude (Saint Paul, MN, USA), Biotronik (Berlin, GER), Sorin Group (Milano, Italy), Abbott (Abbott Park, North Chicago, IL, USA), Bayer AG (Leverkusen, GER), Bristol-Myers Squibb (New York City, NY, USA) and Servier (Neuilly-sur-Seine, FRA).
Funding
This survey was sponsored by Medtronic (Minneapolis, MN, USA), Boston Scientific (Marlborough, MA, USA), St. Jude (Saint Paul, MN, USA), Biotronik (Berlin, GER), Microport (Shanghai, China, formerly SORIN, Milano, Italy), Abbott (Abbott Park, North Chicago, IL, USA), Bayer AG (Leverkusen, GER), Bristol-Myers Squibb (New York City, NY, USA) and Servier (Neuilly-sur-Seine, FRA) and also supported by the European Society of Cardiology, the Heart Failure Association and the European Heart Rhythm Association.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflicts of interest
Dennis Lawin received financial support for attending symposia from Novartis, Basel, CH. Christoph Stellbrink received research support and speaker fees from Medtronic (Minneapolis, MN, USA), Biotronik (Berlin, GER), Sorin Group (Milano, Italy), Abbott (Abbott Park, North Chicago, IL, USA). No potential conflict of interest was reported by the authors.
Ethics standard
Research was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Rights and permissions
About this article
Cite this article
Lawin, D., Israel, C.W., Linde, C. et al. Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II. Clin Res Cardiol 109, 832–844 (2020). https://doi.org/10.1007/s00392-019-01574-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-019-01574-z